Medication overuse headache: Clinical features, pathogenesis and management

Drug Development Research

Volumn 68, Issue 7, 2007, Pages 449-460

  Couch, James R ^a,b   Lenaerts, Marc E ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic daily headache; Headache; Medication overuse; Rebound

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIMIGRAINE AGENT; BARBITURIC ACID DERIVATIVE; BUTALBITAL; BUTORPHANOL; CODEINE; DEXTROPROPOXYPHENE; DIHYDROERGOCORNINE; DIHYDROERGOTAMINE; DOXEPIN; ERGOTAMINE; ERGOTAMINE DERIVATIVE; EXCEDRIN; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; ISOMETHEPTENE; MECLOFENAMIC ACID; METOCLOPRAMIDE; MORPHINE SULFATE; NALBUPHINE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; OXYCODONE; PARACETAMOL; PETHIDINE; TRAMADOL; TRIPTAN DERIVATIVE; UNINDEXED DRUG;

COMORBIDITY; DRUG ABUSE; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; HUMAN; MEDICAL EDUCATION; MENTAL DISEASE; MIGRAINE; PATHOGENESIS; PATIENT EDUCATION; PROPHYLAXIS; REVIEW; SYNDROME DELINEATION;

EID: 38849187991     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20214     Document Type: Review

References (53)

1. Andersson PG. 1975. Ergotamine headache. Headache 15:118-121.
2. Bahra A, Walsh M, Menon S, Goadsby PJ. 2003. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43:179-190.
3. Baumgartner C, Wessely P, Bingöl C, Maly J, Holzner F. 1989. Long term prognosis of analgesic withdrawal in patients with drug induced headaches. Headache 29:510-514.
4. Bigal M, Rapoport A, Sheftell F, Tepper S, Lipton R. 2007. The International Classification of Headache Disorders revised criteria for chronic migraine - field testing in a headache specialty clinic. Cephalalgia 27:230-234.
5. Bigal ME, Lipton RB. 2006. Modifiable risk factors for migraine progression (or for chronic daily headaches) - clinical lessons. Headache 46:S144-S146.
6. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. 2004. Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes. Cephalalgia 24:483-490.
7. Boes CJ, Capobianco DJ. 2005. Chronic migraine and medication-overuse headache through the ages. Cephalalgia 24:378-390.
8. Couch JR. 1979. Evaluation of amitriptyline in the prophylaxis of migraine headache. Arch Neurol 36:695-699.
9. Couch JR. 2003. Chronic daily headache. Curr Treat Options Neurol 5:467-479.
10. Couch JR, Friedman JK. 2005. Methadone therapy in refractory chronic migraine (CM). Headache 45:830.
11. Couch JR. 2006a. Rebound-withdrawal headache (medication overuse headache). Curr Treat Options Neurol 8:11-19.
12. Couch JR. 2006b. Practice point: can medication overuse headache be treated by abrupt withdrawal of the overused agent? Nat Clin Pract Neurol 2:654-655.
13. Diener HC, Limmroth V. 2004. Medication-overuse headache: a worldwide problem. Lancet Neurol 3:475-483.
14. Freitag FG. 2003. Preventative treatment for migraine and tension-type headaches. Do drugs having effects on muscle spasm and tone have a role? CNS Drugs 17:373-381.
15. Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass S, Bussone G. 2002. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 42:483-490.
16. Headache Classification Committee of the International Headache Society. 1988. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl 7):1-96.
17. Headache Classification Committee of the International Headache Society. 2004. The International Classification of Headache Disorders. 2nd Ed. Cephalalgia 24:S1-S160.
18. Headache Classification Committee,Olesen J, Bousser M-G, Diener H-C, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJA, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ. 2006. New appendix criteria open for a broader concept of chronic migraine Cephalalgia 26:742-746.
19. Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson B. 2001. Management of chronic tension-type headache with tricyclic antidepressant medication, stress-management therapy, and their combination: a randomized controlled trial. JAMA 285:2208-2215.
20. Horton BT, Peters GA. 1963. Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 1:213-220.
21. Jauslin P, Goadsby PJ, Lance JW. 1991. The hospital management of severe migrainous headache. Headache 31:658-660.
22. Jelinski SE, Magnusson JE, Becker WJ; CHORD Study Group. 2007. Factors associated with depression in patients referred to headache specialists. Neurology 68:489-495.
23. Katsarava Z, Diener HC, Limmroth V. 2001. Medication overuse headache. A focus on analgesics, ergot alkaloids, and triptans. Drug Safety 24:921-927.
24. Katsarava Z, Limmroth V, Finde M, Diener HC, Fritsche G. 2003. Rate and predictors for relapses in medication overuse headache: a one year prospective study. Neurology 60:1682-1683.
25. Krymchantowski AV, Barbosa JS. 2000. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 20:107-113.
26. Kudrow L. 1982. Paradoxical effects of frequent analgesic use. Adv Neurol 33:335-341.
27. Lake AE III. 2006. Medication overuse headache: biobehavioral issues and solutions. Headache 46:S88-S97.
28. Lance F, Parkes C, Wilkinson M. 1998. Does analgesic abuse cause headache de novo? Headache 38:61-62.
29. Lenaerts M, Bastings E, Sianard J, Schoenen J. 1996. Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels. Acta Neurol Belg 96:126-129.
30. Mathew NT. 1993. Transformed migraine. Cephalalgia 13(Suppl 12):78-83.
31. Mathew NT, Stubits E, Nigam MP. 1982. Transformation of episodic migraine into daily headache: analysis of factors. Headache 22:66-68.
32. Mathew NT, Kurman R, Perez F. 1990. Drug induced refractory headache - clinical features and management. Headache 30:634-638.
33. Pascual J, Colas R, Castillo J. 2001. Epidemiology of chronic daily headache. Curr Pain Headache Rep 5:529-536.
34. Pascual J, Rivas MT, Leira R. 2007. Testing the combination beta-blocker plus topiramate in refractory migraine. Acta Neurol Scand 115:81-83.
35. Peters GA, Horton BT. 1950. Headache with special reference to the excessive use of ergotamine tartrate and dihydroergotamine. J Lab Clin Med 36:972.
36. Rapoport AM. 1988. Analgesic rebound headache. Headache 28:662-665.
37. Rapoport A, Weeks R, Sheftell F. 1985. Analgesic rebound headache: theoretical and practical implications. In: Olesen J, Tfelt-Hansen P, Jensen K, editors. Proceedings Second International Headache Congress, Copenhagen. p 448-449.
38. Saper JR, Dodick D, Gladstone JP. 2005. Management of chronic daily headache: challenges in clinical practice. Headache 45:S74-S85.
39. Saper JR, Lake AE III. 2006. Medication overuse headache: type I and type II. Cephalalgia 26. 1262.
40. Scher AI, Stewart WF, Lieberman J, Lipton RB. 1998. Prevalence of frequent headache in a population sample. Headache 38:497-506.
41. Schnider P, Aull S, Baumgartner C, Marterer A, Wöber C, Zeiler K, Wessely P. 1996. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 16:481-485.
42. Silberstein SD, Schulman EA, Hopkins MM. 1990. Repetitive intravenous DHE in the treatment of refractory headache. Headache 30:334-339.
43. Silberstein SD, Lipton RL, Sliwinski M. 1996. Classification of daily and near-daily headaches: field trial of IHS criteria. Neurology 46:871-875.
44. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J; on behalf of the Topiramate Chronic Migraine Study Group. 2007. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 47:170-180.
45. Srikiatkhachorn A. 2002. Chronic daily headache: a scientist's perspective. Headache 42:532-537.
46. Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. 1999. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 19:5-49.
47. Trucco M, Meineri P, Ruiz L. 2005. Gruppo Neurologico Ospedaliero Interregionale per lo Studio delle Cefalee (Neurological Hospital Interregional Group for the Study of Headache. Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache. J Headache Pain 6:334-337.
48. Wang SJ, Full JL, Lu SR, Juang KD. 2007. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study. Neurology 68:591-596.
49. Warner JS. 2001 Prolonged recovery from rebound headaches. Headache 41:817-822.
50. Wiendels NJ, Knuistingh Neven A, Rosendaal FR, Spinhoven P, Zitman FG, Assendelft WJ, Ferrari MD. 2006. Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia 26:1434-4142.
51. Young WB. 2004. Clinical science: treatment of medication overuse headache and long-term outcome. Headache Curr 1:55-59.
52. Zeeberg P, Olesen J, Jensen R. 2006. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 26:1192-1198.
53. Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J. 2003. Analgesic use: a predictor of chronic pain and medication overuse headache. The Head-HUNT Study. Neurology 61:160-164.